HSIC
HENRY SCHEIN INC
NASDAQ · Healthcare · Medical - Distribution · US
$84.84
−0.24%Aug 18, 2026, 13:55 UTC
Henry Schein reported stronger Q2 sales and margins, prompting a raised 2026 outlook.
Source:Aug 4, 2026, 10:00 UTC
Henry Schein reported financial results for the second quarter ended June 27, 2026, with strong sales performance and margin improvement, and raised its FY2026 guidance.
Jul 30, 2026, 00:00 UTC
Henry Schein Inc announced that Michael S. Ettinger, Mark E. Mlotek, and James (Jim) Mullins will transition to Senior Advisor roles effective October 30, 2026.
Jul 13, 2026, 17:09 UTC
Taiwanese diagnostics company signed a distribution agreement with Henry Schein, a US medical equipment supplier, to expand its in-vitro diagnostics market in the United States.
Source:Jun 30, 2026, 13:00 UTC
GoTu Technology and Henry Schein announced a strategic partnership to help dental practices address staffing challenges through GoTu's talent marketplace platform.
Source: